comparemela.com

Latest Breaking News On - 019 novel coronavirus - Page 12 : comparemela.com

Long COVID Has Caused Thousands of US Deaths: New CDC Data

Fresh estimates from the CDC show a growing death tally from long COVID – with numbers expected to increase as diagnostic expertise improves.

United statesZiyad al alyRobert andersonMark czeislerAmerica indianLouis health care systemVeterans affairsWashington university in stUs centers for diseaseHarvard medical schoolDisease controlWashington universityCovid 19019 novel coronavirus019 ncovUhan coronavirus

Long COVID: New Info on Who Is Most Likely to Get It

Fresh research and clinical anecdotes have given experts a much clearer picture of which patients are most likely to develop long COVID.

United statesUnited kingdomAlba azolaMark bayleyUniversity of queenslandCenters forPrevention household pulseToronto rehabilitation institute at university health networkUniversity of torontoToronto rehabilitation instituteUniversity health networkTemerty facultyNorthwestern medicinePhysical medicineJohns hopkins medicineImmune dysfunction

Monoclonal Antibodies: A New Treatment for Long COVID?

A small study generated impressive results.

United statesFort lauderdalePaul pepeMichael pelusoNancy klimasAileen martyUniversity of texas health sciences centerResearch isInstitute for neuroSchool of public healthDrug administrationUniversity of california san franciscoAmerican journalEmergency medicinePublic healthTexas health sciences

COVID Strain JN 1 Is Now a Variant of Interest, WHO Says

JN.1 was previously grouped with its relative, BA.2.86, but has increased so much in the past 4 weeks that the WHO moved it to standalone status.

United statesNew zealandJohn brownsteinWorld health organizationWestern pacificBoston childrenCovid 19019 novel coronavirus019 ncovUhan coronavirusUman coronavirus hku1Uman coronavirus oc43Cov oc43Uman coronavirus 229eCov 229eCorona virus

When s Best to Re-dose Rituximab After Vasculitis Remission?

A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic antibody vasculitis.

United statesJohnl nilesRobert hyllandGlomerulonephritis center at massachusettsHarvard medical schoolMichigan state university college of osteopathic medicineGlomerulonephritis centerMassachusetts general hospitalMedscape medicalMichigan state university collegeOsteopathic medicineBiologic therapyAntineoplastic drugNti cancer agentsMonoclonal antibodyCovid 19

vimarsana © 2020. All Rights Reserved.